Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Functions”

919 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 919 results

Not applicableStudy completedNCT01098500
What this trial is testing

Liver Function Test (LFT) Elevations in Cancer Patients and Users of Tyrosine Kinase Inhibitor (TKI) Drugs

Who this might be right for
Cancer
GlaxoSmithKline 3,800
Not applicableStudy completedNCT01834300
What this trial is testing

The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non Alcoholic Fatty Liver Disease
University of Liverpool 60
Not applicableWithdrawnNCT00605800
What this trial is testing

Bone Marrow Derived Adult Liver Stem Cell Recruitment After Major Liver Resections: Correlation With Liver Regeneration and Hepatic Function

Who this might be right for
Liver Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Ended earlyNCT02050815
What this trial is testing

MEK162 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function

Who this might be right for
Hepatic Impairment
Array Biopharma, now a wholly owned subsidiary of Pfizer 27
Not applicableStudy completedNCT02597790
What this trial is testing

A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects

Who this might be right for
HIVHepatitis C
University of California, Los Angeles 87
Early research (Phase 1)Study completedNCT01631097
What this trial is testing

A Single-Dose Study of Tivozanib in Subjects With Hepatic Impairment and Normal Hepatic Function

Who this might be right for
Hepatic Impairment
AVEO Pharmaceuticals, Inc. 44
Early research (Phase 1)UnknownNCT00935454
What this trial is testing

Hepatocyte Matrix Implant Study

Who this might be right for
Liver DiseaseLiver Cirrhosis
Baermed 10
Early research (Phase 1)Study completedNCT00419237
What this trial is testing

Investigating The Pharmacokinetics Of An Inhaled Dose Of A New Corticosteroid In Patients With Impaired Liver Function

Who this might be right for
Asthma
GlaxoSmithKline 20
Not applicableLooking for participantsNCT06225193
What this trial is testing

Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population

Who this might be right for
Fatty Liver
Methodist Health System 300
Early research (Phase 1)Study completedNCT03627754
What this trial is testing

Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Glasdegib

Who this might be right for
Hepatic Impairment
Pfizer 24
Early research (Phase 1)Study completedNCT02611505
What this trial is testing

Assess the Effects of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine

Who this might be right for
Hepatic ImpairmentNormal Hepatic Function
Janssen Research & Development, LLC 24
Early research (Phase 1)Study completedNCT02586194
What this trial is testing

Pharmacokinetics Study in Patients With Impaired Hepatic Function

Who this might be right for
Patients With Impaired Hepatic Function
Astellas Pharma Inc 24
Early research (Phase 1)Study completedNCT04016077
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of PF-06651600 in Subjects With Hepatic Impairment and Healthy Volunteers

Who this might be right for
Hepatic ImpairmentHealthy Participants
Pfizer 18
Early research (Phase 1)Not Yet RecruitingNCT07055412
What this trial is testing

Y-3 for Injection in Patients With Hepatic Insufficiency and Healthy Subjects

Who this might be right for
Pharmacokinetic DifferencesY-3Saftey+3 more
Neurodawn Pharmaceutical Co., Ltd. 24
Early research (Phase 1)Study completedNCT02871570
What this trial is testing

Evaluate the Effect of IV Doses of Rivipansel in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function

Who this might be right for
Moderate Hepatic ImpairmentNormal Hepatic Function
GlycoMimetics Incorporated 16
Not applicableUnknownNCT00188201
What this trial is testing

Neurocognitive Functioning in Patients With Hepatitis C Pre- and Post-Treatment With Antiviral Medication

Who this might be right for
Hepatitis CHepatitis B
University Health Network, Toronto 150
Not applicableStudy completedNCT03408171
What this trial is testing

Comparison of 19g FNA and 19g FNB Needles for EUS-LB

Who this might be right for
Abnormal Liver Function
Geisinger Clinic 40
Testing effectiveness (Phase 2)Ended earlyNCT00811434
What this trial is testing

Study of Lactulose in Children With Chronic Liver Disease

Who this might be right for
Minimal Hepatic Encephalopathy
Indiana University 16
Not applicableUnknownNCT02510963
What this trial is testing

Optimal Time for Tenofovir Treatment of Anti-Hepatitis B Virus (HBV) During the Pregnancy

Who this might be right for
Hepatitis B, Chronic
First Affiliated Hospital Xi'an Jiaotong University 300
Early research (Phase 1)Study completedNCT05882032
What this trial is testing

LY3502970 in Participants With Impaired and Normal Liver Function

Who this might be right for
HealthyHepatic Insufficiency
Eli Lilly and Company 29
Next Page